Results 191 to 200 of about 80,955 (206)

DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity

DNA Repair, 2015
Atiq Faramarz, Martin A Rooimans, Saskia E Van Mil   +2 more
exaly  

PARP and PARP Inhibitor Therapeutics

2013
openaire   +1 more source

PARP Inhibitors

2006
openaire   +1 more source

DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity

Cell, 2018
Rajat Gupta, Kumar Somyajit, Takeo Narita   +2 more
exaly  

PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells

Trends in Cell Biology, 2019
Sylvie M Noordermeer, Haico Van Attikum
exaly  

Olaparib: an oral PARP-1 and PARP-2 inhibitor with promising activity in ovarian cancer

Future Oncology, 2015
Camille C Gunderson, Kathleen N Moore
exaly  

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Shahneen Sandhu, Craig P Carden   +2 more
exaly  

BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide

Gynecologic Oncology, 2009
Marie-Claude Beauchamp, Amber Yasmeen, Joan M Carboni   +2 more
exaly  

PARP Inhibitors

2017
openaire   +1 more source

A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity

DNA Repair, 2008
Christopher J Lord, Nicholas C Turner
exaly